Mitchell Kapoor Score: 27
Analyst at
H.C. Wainwright
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+1.0%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
38%
15 W / 25 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
59%
16 W / 11 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
11%
3 W / 24 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 27 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
36%
13 W / 23 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
36%
14 W / 25 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
1 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 08, 2026 |
Halozyme Therapeutics Inc.
HALO
|
BUY |
$130.00
Est. +17%
|
$110.79 | $133.96 |
Target Met
|
$130.34
+17.6%
|
| Sep 28, 2026 |
Incyte Corp.
INCY
|
BUY |
$152.00
Est. +23%
|
$123.89 | $126.18 |
Pending
|
$122.89
-0.8%
|
| Jul 30, 2026 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$115.00
Est. +113%
|
$54.04 | $64.18 |
Pending
|
$40.15
-25.7%
|
| Jul 08, 2026 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$80.00
Est. +32%
|
$60.77 | $61.55 |
Pending
|
$51.78
-14.8%
|
| Jun 11, 2026 |
Damora Therapeutics, Inc.
DMRA
|
BUY |
$45.00
Est. +123%
|
$20.15 | $23.40 |
Pending
|
$22.94
+13.8%
|
| Jun 10, 2026 |
Incyte Corp.
INCY
|
BUY |
$140.00
Est. +36%
|
$103.23 | $132.58 |
Pending
|
$122.89
+19.0%
|
| May 26, 2026 |
Evommune, Inc.
EVMN
|
BUY |
$50.00
Est. +119%
|
$22.87 | $25.87 |
Pending
|
$6.04
-73.6%
|
| May 19, 2026 |
Korro Bio Inc.
KRRO
|
BUY |
$15.00
Est. +50%
|
$9.97 | $17.35 |
Target Met
|
$16.62
+66.7%
|
| May 15, 2026 |
Alumis Inc.
ALMS
|
BUY |
$25.00
Est. +2%
|
$24.63 | $31.35 |
Target Met
|
$6.55
-73.4%
|
| May 15, 2026 |
Kyverna Therapeutics Inc.
KYTX
|
BUY |
$25.00
Est. +133%
|
$10.74 | $10.72 |
Pending
|
$5.16
-52.0%
|
| May 08, 2026 |
Generate Biomedicines, Inc.
GENB
|
BUY |
$25.00
Est. +84%
|
$13.59 | $22.67 |
Pending
|
$14.16
+4.2%
|
| Apr 29, 2026 |
Halozyme Therapeutics Inc.
HALO
|
BUY |
$95.00
Est. +49%
|
$63.86 | $133.96 |
Target Met
|
$130.34
+104.1%
|
| Feb 17, 2026 |
Tyra Biosciences Inc
TYRA
|
BUY |
$45.00
Est. +61%
|
$27.99 | $40.65 |
Pending
|
$21.53
-23.1%
|
| Feb 10, 2026 |
Evommune, Inc.
EVMN
|
BUY |
$65.00
Est. +126%
|
$28.81 | $31.97 |
Pending
|
$6.04
-79.0%
|
| Jan 13, 2026 |
Lexeo Therapeutics Inc.
LXEO
|
BUY |
$10.00
Est. +23%
|
$8.12 | $8.11 |
Pending
|
$3.23
-60.2%
|
| Jan 06, 2026 |
Evommune, Inc.
EVMN
|
BUY |
$35.00
Est. +128%
|
$15.37 | $31.97 |
Pending
|
$6.04
-60.7%
|
| Dec 18, 2025 |
Alumis Inc.
ALMS
|
BUY |
$20.00
Est. +82%
|
$11.00 | $31.35 |
Target Met
|
$6.55
-40.5%
|
| Nov 24, 2025 |
MeiraGTx Holdings plc
MGTX
|
BUY |
$20.00
Est. +168%
|
$7.46 | $15.35 |
Pending
|
$9.42
+26.3%
|
| Oct 30, 2025 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$18.00
Est. +37%
|
$13.12 | $18.48 |
Precision Hit (±3%)
|
$12.31
-6.2%
|
| Oct 27, 2025 |
Intellia Therapeutics Inc
NTLA
|
SELL |
$25.00
Est. +2%
|
$25.60 | $7.95 (Low) |
Target Met
|
$12.31
+51.9%
|
| Oct 27, 2025 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$40.00
Est. +47%
|
$27.25 | $112.95 |
Target Met
|
$101.41
+272.1%
|
| Sep 02, 2025 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$95.00
Est. +65%
|
$57.49 | $86.74 |
Miss
|
$40.15
-30.2%
|
| Apr 03, 2025 |
Zura Bio Ltd - Ordinary Shares - Class A
ZURA
|
BUY |
$3.00
Est. +175%
|
$1.09 | $7.44 |
Target Met
|
$4.02
+268.8%
|
| Mar 25, 2025 |
Neurogene Inc
NGNE
|
BUY |
$50.00
Est. +252%
|
$14.20 | $37.06 |
Miss
|
$27.58
+94.2%
|
| Mar 12, 2025 |
Legend Biotech Corp - ADR
LEGN
|
BUY |
$75.00
Est. +102%
|
$37.19 | $45.30 |
Miss
|
$22.77
-38.8%
|
| Feb 03, 2025 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$65.00
Est. +63%
|
$40.00 | $78.48 |
Target Met
|
$51.78
+29.4%
|
| Nov 11, 2024 |
Tyra Biosciences Inc
TYRA
|
BUY |
$30.00
Est. +80%
|
$16.70 | $17.27 |
Miss
|
$21.53
+28.9%
|
| Nov 06, 2024 |
Verve Therapeutics Inc
VERV
|
BUY |
$14.00
Est. +122%
|
$6.32 | $11.40 |
Miss
|
$11.13
+76.1%
|
| Nov 06, 2024 |
Century Therapeutics Inc
IPSC
|
BUY |
$5.00
Est. +260%
|
$1.39 | $1.83 |
Miss
|
$1.67
+20.1%
|
| Oct 17, 2024 |
Alumis Inc.
ALMS
|
BUY |
$30.00
Est. +172%
|
$11.03 | $13.11 |
Miss
|
$6.55
-40.6%
|
| Sep 16, 2024 |
Summit Therapeutics Inc
SMMT
|
BUY |
$45.00
Est. +41%
|
$31.93 | $36.91 |
Miss
|
$16.17
-49.4%
|
| Sep 16, 2024 |
Instil Bio Inc
TIL
|
BUY |
$120.00
Est. +42%
|
$84.52 | $76.13 |
Miss
|
$6.99
-91.7%
|
| Sep 12, 2024 |
Instil Bio Inc
TIL
|
BUY |
$40.00
Est. +2%
|
$39.19 | $92.00 |
Target Met
|
$6.99
-82.2%
|
| Sep 05, 2024 |
Zura Bio Ltd - Ordinary Shares - Class A
ZURA
|
BUY |
$5.00
Est. +27%
|
$3.95 | $5.07 |
Precision Hit (±3%)
|
$4.02
+1.8%
|
| Aug 21, 2024 |
Metagenomi Inc.
MGX
|
BUY |
$7.00
Est. +112%
|
$3.30 | $4.92 |
Miss
|
$0.79
-76.1%
|
| Aug 12, 2024 |
Neurogene Inc
NGNE
|
BUY |
$49.00
Est. +38%
|
$35.59 | $74.49 |
Target Met
|
$27.58
-22.5%
|
| Aug 09, 2024 |
Cartesian Therapeutics Inc
RNAC
|
BUY |
$45.00
Est. +250%
|
$12.87 | $26.50 |
Miss
|
$6.82
-47.0%
|
| Aug 08, 2024 |
Tyra Biosciences Inc
TYRA
|
BUY |
$25.00
Est. +28%
|
$19.50 | $29.60 |
Target Met
|
$21.53
+10.4%
|
| Jun 07, 2024 |
Halozyme Therapeutics Inc.
HALO
|
BUY |
$65.00
Est. +26%
|
$51.44 | $70.51 |
Target Met
|
$130.34
+153.4%
|
| Mar 20, 2024 |
Tyra Biosciences Inc
TYRA
|
BUY |
$23.00
Est. +32%
|
$17.37 | $29.60 |
Target Met
|
$21.53
+23.9%
|
Halozyme Therapeutics Inc.
HALO
Oct 08, 2026
Signal & Target
BUY
$130.00
Start Price
$110.79
Best Price (1Y)
$133.96
Current Price
$130.34
Return
+17.6%
Incyte Corp.
INCY
Sep 28, 2026
Signal & Target
BUY
$152.00
Start Price
$123.89
Best Price (1Y)
$126.18
Current Price
$122.89
Return
-0.8%
Ionis Pharmaceuticals Inc
IONS
Jul 30, 2026
Signal & Target
BUY
$115.00
Start Price
$54.04
Best Price (1Y)
$64.18
Current Price
$40.15
Return
-25.7%
CRISPR Therapeutics AG
CRSP
Jul 08, 2026
Signal & Target
BUY
$80.00
Start Price
$60.77
Best Price (1Y)
$61.55
Current Price
$51.78
Return
-14.8%
Damora Therapeutics, Inc.
DMRA
Jun 11, 2026
Signal & Target
BUY
$45.00
Start Price
$20.15
Best Price (1Y)
$23.40
Current Price
$22.94
Return
+13.8%
Incyte Corp.
INCY
Jun 10, 2026
Signal & Target
BUY
$140.00
Start Price
$103.23
Best Price (1Y)
$132.58
Current Price
$122.89
Return
+19.0%
Evommune, Inc.
EVMN
May 26, 2026
Signal & Target
BUY
$50.00
Start Price
$22.87
Best Price (1Y)
$25.87
Current Price
$6.04
Return
-73.6%
Korro Bio Inc.
KRRO
May 19, 2026
Signal & Target
BUY
$15.00
Start Price
$9.97
Best Price (1Y)
$17.35
Current Price
$16.62
Return
+66.7%
Alumis Inc.
ALMS
May 15, 2026
Signal & Target
BUY
$25.00
Start Price
$24.63
Best Price (1Y)
$31.35
Current Price
$6.55
Return
-73.4%
Kyverna Therapeutics Inc.
KYTX
May 15, 2026
Signal & Target
BUY
$25.00
Start Price
$10.74
Best Price (1Y)
$10.72
Current Price
$5.16
Return
-52.0%
Generate Biomedicines, Inc.
GENB
May 08, 2026
Signal & Target
BUY
$25.00
Start Price
$13.59
Best Price (1Y)
$22.67
Current Price
$14.16
Return
+4.2%
Halozyme Therapeutics Inc.
HALO
Apr 29, 2026
Signal & Target
BUY
$95.00
Start Price
$63.86
Best Price (1Y)
$133.96
Current Price
$130.34
Return
+104.1%
Tyra Biosciences Inc
TYRA
Feb 17, 2026
Signal & Target
BUY
$45.00
Start Price
$27.99
Best Price (1Y)
$40.65
Current Price
$21.53
Return
-23.1%
Evommune, Inc.
EVMN
Feb 10, 2026
Signal & Target
BUY
$65.00
Start Price
$28.81
Best Price (1Y)
$31.97
Current Price
$6.04
Return
-79.0%
Lexeo Therapeutics Inc.
LXEO
Jan 13, 2026
Signal & Target
BUY
$10.00
Start Price
$8.12
Best Price (1Y)
$8.11
Current Price
$3.23
Return
-60.2%
Evommune, Inc.
EVMN
Jan 06, 2026
Signal & Target
BUY
$35.00
Start Price
$15.37
Best Price (1Y)
$31.97
Current Price
$6.04
Return
-60.7%
Alumis Inc.
ALMS
Dec 18, 2025
Signal & Target
BUY
$20.00
Start Price
$11.00
Best Price (1Y)
$31.35
Current Price
$6.55
Return
-40.5%
MeiraGTx Holdings plc
MGTX
Nov 24, 2025
Signal & Target
BUY
$20.00
Start Price
$7.46
Best Price (1Y)
$15.35
Current Price
$9.42
Return
+26.3%
Intellia Therapeutics Inc
NTLA
Oct 30, 2025
Signal & Target
BUY
$18.00
Start Price
$13.12
Best Price (1Y)
$18.48
Current Price
$12.31
Return
-6.2%
Intellia Therapeutics Inc
NTLA
Oct 27, 2025
Signal & Target
SELL
$25.00
Start Price
$25.60
Best Price (1Y)
$7.95
Current Price
$12.31
Return
+51.9%
Oruka Therapeutics, Inc.
ORKA
Oct 27, 2025
Signal & Target
BUY
$40.00
Start Price
$27.25
Best Price (1Y)
$112.95
Current Price
$101.41
Return
+272.1%
Ionis Pharmaceuticals Inc
IONS
Sep 02, 2025
Signal & Target
BUY
$95.00
Start Price
$57.49
Best Price (1Y)
$86.74
Current Price
$40.15
Return
-30.2%
Zura Bio Ltd - Ordinary Shares - Class A
ZURA
Apr 03, 2025
Signal & Target
BUY
$3.00
Start Price
$1.09
Best Price (1Y)
$7.44
Current Price
$4.02
Return
+268.8%
Neurogene Inc
NGNE
Mar 25, 2025
Signal & Target
BUY
$50.00
Start Price
$14.20
Best Price (1Y)
$37.06
Current Price
$27.58
Return
+94.2%
Legend Biotech Corp - ADR
LEGN
Mar 12, 2025
Signal & Target
BUY
$75.00
Start Price
$37.19
Best Price (1Y)
$45.30
Current Price
$22.77
Return
-38.8%
CRISPR Therapeutics AG
CRSP
Feb 03, 2025
Signal & Target
BUY
$65.00
Start Price
$40.00
Best Price (1Y)
$78.48
Current Price
$51.78
Return
+29.4%
Tyra Biosciences Inc
TYRA
Nov 11, 2024
Signal & Target
BUY
$30.00
Start Price
$16.70
Best Price (1Y)
$17.27
Current Price
$21.53
Return
+28.9%
Verve Therapeutics Inc
VERV
Nov 06, 2024
Signal & Target
BUY
$14.00
Start Price
$6.32
Best Price (1Y)
$11.40
Current Price
$11.13
Return
+76.1%
Century Therapeutics Inc
IPSC
Nov 06, 2024
Signal & Target
BUY
$5.00
Start Price
$1.39
Best Price (1Y)
$1.83
Current Price
$1.67
Return
+20.1%
Alumis Inc.
ALMS
Oct 17, 2024
Signal & Target
BUY
$30.00
Start Price
$11.03
Best Price (1Y)
$13.11
Current Price
$6.55
Return
-40.6%
Summit Therapeutics Inc
SMMT
Sep 16, 2024
Signal & Target
BUY
$45.00
Start Price
$31.93
Best Price (1Y)
$36.91
Current Price
$16.17
Return
-49.4%
Instil Bio Inc
TIL
Sep 16, 2024
Signal & Target
BUY
$120.00
Start Price
$84.52
Best Price (1Y)
$76.13
Current Price
$6.99
Return
-91.7%
Instil Bio Inc
TIL
Sep 12, 2024
Signal & Target
BUY
$40.00
Start Price
$39.19
Best Price (1Y)
$92.00
Current Price
$6.99
Return
-82.2%
Zura Bio Ltd - Ordinary Shares - Class A
ZURA
Sep 05, 2024
Signal & Target
BUY
$5.00
Start Price
$3.95
Best Price (1Y)
$5.07
Current Price
$4.02
Return
+1.8%
Metagenomi Inc.
MGX
Aug 21, 2024
Signal & Target
BUY
$7.00
Start Price
$3.30
Best Price (1Y)
$4.92
Current Price
$0.79
Return
-76.1%
Neurogene Inc
NGNE
Aug 12, 2024
Signal & Target
BUY
$49.00
Start Price
$35.59
Best Price (1Y)
$74.49
Current Price
$27.58
Return
-22.5%
Cartesian Therapeutics Inc
RNAC
Aug 09, 2024
Signal & Target
BUY
$45.00
Start Price
$12.87
Best Price (1Y)
$26.50
Current Price
$6.82
Return
-47.0%
Tyra Biosciences Inc
TYRA
Aug 08, 2024
Signal & Target
BUY
$25.00
Start Price
$19.50
Best Price (1Y)
$29.60
Current Price
$21.53
Return
+10.4%
Halozyme Therapeutics Inc.
HALO
Jun 07, 2024
Signal & Target
BUY
$65.00
Start Price
$51.44
Best Price (1Y)
$70.51
Current Price
$130.34
Return
+153.4%
Tyra Biosciences Inc
TYRA
Mar 20, 2024
Signal & Target
BUY
$23.00
Start Price
$17.37
Best Price (1Y)
$29.60
Current Price
$21.53
Return
+23.9%